ArticlePloS one2025

Adjuvant Icotinib in EGFR-mutated stage IB non-small cell lung cancer with high-risk factors: A retrospective case series.

Mengzhi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.